The Europe diabetic assays market was valued at USD 1,005.40 million in 2022 and is projected to reach USD 1,418.90 million by 2030. The market is expected to grow at a compound annual growth rate (CAGR) of 4.4% during the forecast period from 2023 to 2030. Germany stands out as the leading country in the region, driven by advanced healthcare...
เกี่ยวกับ
เงื่อนไข
ความเป็นส่วนตัว
Contact
Invest
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian